Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 11619

Saint Charles, MO 63301


Study Summary:

A randomized phase 2A, double-blind, placebo-controlled study of the efficacy and safety of CP-601,927 augmentation of antidepressant therapy in major depression.


Qualified Participants Must:

• Be 18 to 65 years of age
• Have a primary current diagnosis of MDD (Major Depressive Disorder)
• Be a non-smoker
• Be on an antidepressant and not have a full response to the medication
• Be physically healthy


Qualified Participants May Receive:

Doctor visits, study medication, study evaluations, and compensation for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.